← Back to blog
aging

NAD+ Benefits: What It Does, How It Declines & What Research Shows

By TelosRX Editorial Team August 18, 2026
Two women hiking on a mountain trail

NAD+ (nicotinamide adenine dinucleotide) is a coenzyme found in every cell of your body that drives energy production, DNA repair, and sirtuin-linked longevity pathways. Levels decline roughly 50% between your 20s and 60s—a drop researchers associate with reduced cellular function. Explore your options at TelosRX, subject to medical approval by a licensed provider.

NAD+ isn't a supplement in the traditional sense. It's a molecule your body already produces and uses constantly—for metabolism, for repairing DNA damage, for regulating the proteins that influence how your cells age. The research interest in supporting NAD+ levels isn't wellness hype; it's rooted in decades of molecular biology that keeps producing provocative findings. This article explains what NAD+ actually does, what the research shows for specific benefit categories, and where the evidence gaps honestly stand.

What Is NAD+ and Why Do Levels Decline?

NAD+ stands for nicotinamide adenine dinucleotide. It cycles between two forms: NAD+ (the oxidized, active form) and NADH (the reduced form). Your cells constantly shuttle between the two, passing electrons to drive metabolic reactions—particularly in the mitochondria, where your body generates energy.

NAD+ levels decline with age for several documented reasons:

  • CD38 increases: This enzyme consumes NAD+ and rises with age and chronic inflammation
  • PARP demand rises: DNA damage accumulates with age; PARP enzymes use NAD+ to repair it
  • Biosynthesis slows: The enzymatic pathways that make NAD+ from dietary precursors become less efficient with age
Age Range Estimated NAD+ Level (Relative) Observed in Research
20s ~100% Peak cellular function baseline
40s ~70% Early mitochondrial efficiency changes in animal models
50s ~50% Decline correlates with metabolic changes in observational data
60s+ ~35–40% Accelerated loss in high-demand tissues

These estimates draw from tissue-specific animal research; direct human measurements vary by tissue and individual. The 50% decline figure is from a widely cited 2021 review in Nature Reviews Molecular Cell Biology (Covarrubias et al.).

How NAD+ Powers Energy Production

Your mitochondria produce ATP—the energy currency your cells use for everything from muscle contraction to thought. NAD+ is the central electron carrier in this process. It accepts electrons from metabolized nutrients (carbohydrates, fats, proteins), carries them into the electron transport chain, and helps drive ATP production through oxidative phosphorylation.

Without adequate NAD+, this process runs less efficiently. A 2016 study published in Science (Zhang et al., PMID 27127236) showed that NAD+ repletion in aged mice improved mitochondrial function and extended healthspan markers—one of the most-cited studies in this space.

Human data for injectable NAD+ specifically is limited. Small studies and case series suggest some people experience reduced fatigue, but these lack the control groups and sample sizes needed to draw firm conclusions. The gap between strong animal evidence and confirmed human benefit remains significant for energy-specific claims.

Evidence level: Strong mechanistic basis and compelling animal data. Human evidence for injectable NAD+ is preliminary.

NAD+ and DNA Repair: The PARP Connection

PARP enzymes (poly ADP-ribose polymerases) are your cells' frontline DNA repair system. When DNA sustains damage from UV radiation, oxidative stress, or normal metabolic byproducts, PARPs use NAD+ as their fuel to identify and fix the breaks. As NAD+ declines with age, PARP efficiency decreases and unrepaired DNA damage accumulates.

Sirtuin proteins—a family of seven deacetylases sometimes called "longevity genes"—also require NAD+ to function. Sirtuins regulate gene expression, inflammation, and mitochondrial health. Animal research has linked sirtuin activation to extended lifespan in yeast, worms, and rodents. Human translation is under active investigation but not yet established.

Evidence level: Strong mechanistic basis (PARP and sirtuin biology are well-characterized). Animal lifespan data is supportive. No direct human proof of anti-aging effects from NAD+ supplementation.

NAD+ and Metabolic Health: The Strongest Human Data

The most rigorous human evidence in the NAD+ field comes from a 2021 randomized, double-blind, placebo-controlled trial published in Science. The study found that oral NMN (nicotinamide mononucleotide, a NAD+ precursor) improved skeletal muscle insulin sensitivity in prediabetic women over 10 weeks.

Two important caveats apply. First, the study used oral NMN, not injectable NAD+. Second, NMN is a precursor—your body converts it to NAD+, not NAD+ itself. Extrapolating from oral NMN data to injectable NAD+ requires caution until direct comparative studies exist. Still, this trial is the most methodologically rigorous human study in the NAD+ precursor space.

Evidence level: One well-designed human trial (oral NMN). No equivalent RCT data exists for injectable NAD+.

NAD+ and Cognitive Health

Neurons are among the most energy-intensive cells in the body and high NAD+ consumers. Preclinical research has linked boosted NAD+ levels to reduced neuroinflammation and improved cognitive performance in mouse models of neurodegeneration. A 2018 study in PNAS found that NAD+ supplementation normalized DNA damage responses in a mouse model of Alzheimer's disease with introduced DNA repair deficiency—a mechanistically interesting finding, though conducted in a disease model, not healthy adults.

No controlled human trial has demonstrated that NAD+ injections improve cognition in healthy adults. Reports of improved focus and mental clarity from people receiving NAD+ therapy are anecdotal and consistent with the mechanism but don't constitute clinical evidence.

Evidence level: Promising preclinical data. Human evidence is anecdotal only.

Is NAD+ FDA-Approved?

No. NAD+ is not FDA-approved for any specific medical indication. Compounded NAD+ injections—the form offered through telehealth pharmacies like TelosRX—are not FDA-approved finished drug products. They are prepared under federal compounding regulations. A licensed provider must evaluate suitability and issue a prescription before dispensing.

Quality matters: in 2025, the FDA issued a Class I recall for compounded NAD+ injectable products from one pharmacy due to endotoxin contamination. Choosing a LegitScript-certified pharmacy with pharmaceutical-grade sourcing reduces—though does not eliminate—contamination risk.

How NAD+ Is Delivered: Options Compared

Delivery Method Route GI Bypass Convenience Best Human Evidence
IV Infusion Intravenous Yes Clinic visit (1–4 hrs) Limited; case series only
Subcutaneous Injection Under skin Yes Self-administered at home Limited; emerging
Oral NMN Oral No Daily pill/powder 1 RCT (metabolic health, 2021)
Oral NR Oral No Daily pill Multiple small trials

Injectable formats bypass the gastrointestinal tract and may raise blood NAD+ levels faster than oral precursors. However, no large human trial has compared injectable NAD+ outcomes directly against oral precursors. The current evidence base is strongest for oral NMN.

TelosRX evaluates NAD+ therapy asynchronously. If a licensed provider determines it's appropriate for your health profile, a prescription is issued and your protocol ships. Start your NAD+ evaluation at TelosRX—no office visit required.

Supporting NAD+ Levels: Precursors and Lifestyle

NAD+ is not meaningfully absorbed directly from food. The body builds it from dietary precursors—primarily forms of niacin (vitamin B3). Main approaches to supporting NAD+ levels:

  • NMN — One step from NAD+ in the biosynthesis pathway; the compound used in the 2021 Science human trial
  • NR (nicotinamide riboside) — Multiple small trials show it raises blood NAD+ levels; outcome data still developing. See our NMN vs NR comparison
  • Injectable or IV NAD+ — Bypasses GI tract; potentially faster NAD+ elevation; available through telehealth evaluation
  • Resistance training and aerobic exercise — Both support NAMPT activity, the key enzyme that recycles NAD+; this is the highest-evidence lifestyle strategy for NAD+ support
  • Time-restricted eating — Associated with increased NAD+ and sirtuin activity in animal research; human data is preliminary

For more on the cellular health connection, see the TelosRX overview of NAD+ therapy and cellular support.

Frequently Asked Questions

What does NAD+ actually do?

NAD+ is a coenzyme involved in energy production (via the mitochondrial electron transport chain), DNA repair (via PARP enzymes), and cellular signaling (via sirtuin proteins). It is required for normal metabolic function in every cell. Levels decline naturally with age, prompting research into whether supplementation can restore cellular efficiency.

Is NAD+ FDA-approved?

No. NAD+ is not FDA-approved for any specific medical indication. Compounded NAD+ injections are not FDA-approved finished drug products. They are prepared under federal compounding regulations. Evaluation by a licensed provider is required before a prescription can be issued.

What are the proven benefits of NAD+?

The strongest human evidence involves oral NMN improving insulin sensitivity in prediabetic women (one 2021 RCT in Science). Other benefits—energy, cognition, anti-aging—are supported by strong preclinical (animal) research but have not been confirmed in large-scale human trials. Claims of guaranteed outcomes are not supported by current evidence.

How long does it take to feel NAD+ effects?

There is no established timeline. Some people receiving NAD+ therapy report changes in energy or sleep within days to weeks; others notice no change. Individual variation is high, and no controlled trials have established a standard response timeline for injectable NAD+.

What foods are high in NAD+?

NAD+ isn't meaningfully absorbed from food directly. Your body builds it from precursors found in fish, beef, poultry, mushrooms, and dairy—primarily as forms of niacin or nicotinamide riboside. These dietary sources support NAD+ biosynthesis but don't match the precursor concentrations studied in trials.

Can NAD+ help with aging?

Animal research has linked NAD+ restoration to improved lifespan and healthspan markers in multiple species. No human trial has demonstrated that NAD+ supplementation extends lifespan or reverses aging. The mechanistic connection via PARP and sirtuin biology is scientifically credible. "Studies suggest" is the honest frame, not "proven."

Is NAD+ safe?

NAD+ therapy is generally well-tolerated at standard doses. Common side effects include nausea, flushing, and headache—typically mild and transient. Theoretical concerns include supporting cell growth broadly (not selectively), which may be relevant for individuals with active cancer—discuss with an oncologist. Quality of compounded products varies; LegitScript-certified pharmacies reduce contamination risk. Subject to licensed provider evaluation before starting.

TelosRX is LegitScript-certified. Compounded medications are not FDA-approved and are prepared under federal compounding regulations. Approval is subject to evaluation by a licensed provider; approval is not guaranteed. Individual results vary. TelosRX operates as an online-first, asynchronous telehealth service.

Start your private evaluation at TelosRX.

Related research

Compounded medications are compounded, not FDA-approved. Prescriptions are never automatic or guaranteed. TelosRX operates under LegitScript-certified telehealth standards as an online-first, asynchronous telehealth service.

Read more from TelosRX